Moderna increases manufacturing capacity

By The Science Advisory Board staff writers

Moderna has doubled the size of its manufacturing technology center in Norwood, MA, expanding the facility from a production and lab space into an industrial technology center, according to the company.

Moderna's production lab and space has been increased from approximately 300,000 sq ft to approximately 650,000 sq ft. In addition, the firm acquired a 240,000-sq-ft building on the same campus in order to expand its commercial and clinical activities.

The expansion will enable a 50% increase in production of Moderna's COVID-19 vaccine at the manufacturing site beginning in late 2021 and early 2022, according to the company. Late last month, Moderna also announced investments in its owned and partnered manufacturing facilities that it expects would increase 2022 global capacity to up to 3 billion doses of its COVID-19 vaccine. It also raised its 2021 manufacturing supply forecast to be between 800 million and 1 billion doses.

Copyright © 2021

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?